ANDREW BLACK: Open Payments
NPI 1790011724 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,084 in 169 payments from 24 companies in 2025. Trend: 2023 $2,693 · 2024 $3,324 · 2025 $3,084
Food & beverage: $2,994Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $497 |
| AstraZeneca Pharmaceuticals LP | 16 | $397 |
| Novo Nordisk Inc | 19 | $315 |
| Astellas Pharma US Inc | 9 | $278 |
| PFIZER INC. | 19 | $271 |
| Lilly USA, LLC | 17 | $243 |
| Merck Sharp & Dohme LLC | 9 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $143 |
| Abbott Laboratories | 5 | $127 |
| Exact Sciences Corporation | 6 | $114 |
Products named: JARDIANCE, FARXIGA, VRAYLAR, Veozah, Ozempic, NURTEC ODT, MOUNJARO, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
